OK Biotech CoTPE:4155 61 FCF Margin % is 49.15% as of Dec. 2025. GuruFocus rates TPE:4155 with a GF Score™ of 61/100 and a GF Value™ of NT$27.27 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 815 Medical Devices & Instruments companies, OK Biotech Co ranks worse than 59.75% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. OK Biotech Co's Free Cash Flow for the
three
months ended in Dec. 2025 was NT$166 Mil. OK Biotech Co's Revenue for the
three
months ended in Dec. 2025 was NT$338 Mil. Therefore, OK Biotech Co's FCF Margin % for the quarter that ended in Dec. 2025 was 49.15%.
The historical rank and industry rank for OK Biotech Co's FCF Margin % or its related term are showing as below:
TPE:4155'
s FCF Margin % Range Over the Past 10 Years
Min: -36.42 Med: -3.11 Max: 19.58
Current: -5.27
During the past 13 years, the highest FCF Margin % of OK Biotech Co was 19.58%. The lowest was -36.42%. And the median was -3.11%.
TPE:4155's FCF Margin % is ranked worse than 59.75% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: -0.03
vs TPE:4155: -5.27
OK Biotech Co FCF Margin % Related Terms
OK Biotech Co FCF Margin % Historical Data
* Premium members only.
The historical data trend for OK Biotech Co's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:4155 vs ABT, SYK, MDT: FCF Margin % Comparison
For the Medical Devices subindustry, OK Biotech Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
OK Biotech Co FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, OK Biotech Co's FCF Margin % distribution charts can be found below:
* The bar in red indicates where OK Biotech Co's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OK Biotech Co (TPE:4155) has a FCF Margin % of 49.15% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on OK Biotech Co and its competitors. According to the industry distribution chart, OK Biotech Co ranks #487 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 59.8%.
Is OK Biotech Co's FCF Margin % too high?
OK Biotech Co's current FCF Margin % is 49.15%. Based on the distribution chart, OK Biotech Co ranks #487 out of 815 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, OK Biotech Co has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does OK Biotech Co's FCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, OK Biotech Co ranks #487 out of 815 companies for FCF Margin %. This places OK Biotech Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on OK Biotech Co and its competitors. OK Biotech Co's current FCF Margin % is 49.15%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OK Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, OK Biotech Co (TPE:4155) is currently considered Possible Value Trap. The stock's GF Value™ is NT$27.27, compared to a current price of NT$15.00 — trading 45% below its estimated fair value. The current FCF Margin % is 49.15%. OK Biotech Co's overall GF Score™ is 61/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For OK Biotech Co (TPE:4155), the current FCF Margin % is 49.15% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is OK Biotech Co (TPE:4155) Overvalued in 2026?
Based on GuruFocus' analysis, OK Biotech Co stock appears to be undervalued.
The current stock price of NT$15.00 is trading 45% below its estimated GF Value™ of NT$27.27.
GuruFocus considers OK Biotech Co to be Possible Value Trap.
Key valuation signals for TPE:4155:
FCF Margin %: 49.15%
GF Value™: NT$27.27 vs. price of NT$15.00 (45% below fair value)
No single metric tells the full story. See the TPE:4155 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
OK Biotech Co Ltd is mainly engaged in the manufacturing, wholesale, and retail of electronic materials and medical equipment. Its product portfolio comprises blood glucose monitoring systems, OTC hearing aids, multi-frequency therapy devices, and others. Geographically, the company generates the majority of its revenue from America, and the rest from Asia (excluding Taiwan), Africa, Europe, and Taiwan.
61GF Score
Get the complete analysis for TPE:4155
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:4155 has been successfully added to your 
